Assessment of Cefotaxime Susceptibility and Resistance Gene Transfer Risk between Bacillus Strains and Escherichia coli Ec457
Main Article Content
Abstract
Antibiotic resistance in husbandry remains a major global challenge due to the extensive use of antimicrobials in animal production. Probiotics with genetically stable profiles are therefore considered promising alternatives to reduce antibiotic reliance and limit resistance dissemination. This study evaluated the susceptibility of three Bacillus strains: P4QN11, BAD7, and S2.5, and Escherichia coli Ec457 to cefotaxime, and investigated the potential transfer of the bla-CTX-M resistance gene. Disk diffusion assays showed that Bacillus P4QN11, BAD7, and S2.5 had large inhibition zones of 26 to 27 millimeters, indicating high susceptibility, while E. coli Ec457 exhibited a small inhibition zone of 13 ± 1 millimeters, confirming resistance. Cefotaxime resistance of E. coli Ec457 was evidenced by the presence of the blaCTX-M gene detected by PCR. Co-cultivation experiments under selective pressure with LiCl and cefotaxime tested whether Bacillus strains could acquire resistance genes. After repeated co-culture, Bacillus P4QN11, BAD7, and S2.5 remained phenotypically susceptible in disk diffusion tests, and PCR showed no blaCTX-M amplification, confirming gene transfer was not detected. These results demonstrated that the Bacillus strains do not acquire cefotaxime resistance genes from E. coli Ec457, even under selective conditions. This supports their genetic stability and safety for use as probiotics in food and animal feed, help to reduce the spread of antibiotic resistance. Further research should explore longer co-culture periods and genomic analysis to confirm these findings under diverse environmental conditions.
Keywords
Antibiotics, animal feed, blaCTX-M gene, Bacillus strain.
Article Details
References
[2] S. Mingmongkolchai and W. Panbangred, Bacillus probiotics: an alternative to antibiotics for livestock production, Journal of Applied Microbiology, vol. 124, iss. 6, pp. 1334–1346, Jun. 2018. https://doi.org/10.1111/jam.13690
[3] Z. Zhai, C. Cui, X. Li, J. Yan, E. Sun, C. Wang, H. Guo, and Y. Hao, Prevalence, antimicrobial susceptibility, and antibiotic resistance gene transfer of Bacillus strains isolated from pasteurized milk, Journal of Dairy Science, vol. 106, iss. 1, pp. 75–83, Jan. 2023. https://doi.org/10.3168/jds.2022-22199
[4] L. Deng, C. Wang, X. Zhang, H. Tang, X. Chen, S. Du, and X. Chen, Cell-to-cell natural transformation in Bacillus subtilis facilitates large scale of genomic exchanges and the transfer of long continuous DNA regions, Nucleic Acids Research, vol. 51, iss. 8, pp. 3820–3835, May 2023. https://doi.org/10.1093/nar/gkad138
[5] X. Zhang, T. Jin, L. Deng, C. Wang, Y. Zhang, and X. Chen, Stress-induced, highly efficient, donor cell-dependent cell-to-cell natural transformation in Bacillus subtilis, Journal of Bacteriology, vol. 200, no. 17, Aug. 2018. https://doi.org/10.1128/JB.00267-18
[6] F. M. F. Elshaghabee, N. Rokana, R. D. Gulhane, C. Sharma, and H. Panwar, Bacillus as potential probiotics: status, concerns, and future perspectives, Frontiers in Microbiology, vol. 8, Aug. 2017. https://doi.org/10.3389/fmicb.2017.01490
[7] European Food Safety Authority, EFSA statement on the risk posed to humans by a vitamin B2 produced by a genetically modified strain of Bacillus subtilis used as a feed additive, EFSA Journal, vol. 17, no. 4, Apr. 2019. https://doi.org/10.2903/j.efsa.2019.5615
[8] Y. Agersø, K. Bjerre, E. Brockmann, E. Johansen, B. Nielsen, R. Siezen, B. S-Lauridsen, M. Wels, and A. A. Zeidan, Putative antibiotic resistance genes present in extant Bacillus licheniformis and Bacillus paralicheniformis strains are probably intrinsic and part of the ancient resistome, PLoS One, vol. 14, no. 1, Jan. 2019. https://doi.org/10.1371/journal.pone.0210363
[9] A. Raheem, L. Liang, G. Zhang, and S. Cui, Modulatory effects of probiotics during pathogenic infections with emphasis on immune regulation, Frontiers in Immunology, vol. 12, Apr. 2021. https://doi.org/10.3389/fimmu.2021.616713
[10] A. W. Bauer, W. M. Kirby, J. C. Sherris, and M. Turck, Antibiotic susceptibility testing by a standardized single disk method, American Journal of Clinical Pathology, vol. 45, iss. 4, pp. 493–496, Apr. 1966. https://doi.org/10.1093/ajcp/45.4_ts.493
[11] M. P. Weinstein, Performance standards for antimicrobial susceptibility testing, Clinical and Laboratory Standards Institute (CLSI), 2019.
[12] G. M. N. Uddin, M. H. Larsen, H. Christensen, F. M. Aarestrup, T. M. Phu, and A. Dalsgaard, Identification and Antimicrobial Resistance of Bacteria Isolated from Probiotic Products Used in Shrimp Culture, PLoS One, vol. 10, no. 7, Jul. 2015. https://doi.org/10.1371/journal.pone.0132338
[13] M. Dieser, H. J. Smith, and C. M. Foreman, Seven genome sequences of airborne, bacterial isolates from Antarctica, Microbiology Resource Announcements, vol. 13, no. 6, May 2024. https://doi.org/10.1128/mra.01129-23
[14] R. A. Mir, T. A. Weppelmann, L. Teng, A. Kirpich, M. A. Elzo, J. D. Driver, and K. C. Jeong, Colonization dynamics of cefotaxime resistant bacteria in beef cattle raised without cephalosporin antibiotics, Frontiers in Microbiology, vol. 9, Mar. 2018. https://doi.org/10.3389/fmicb.2018.00500
[15] A. A. Adegoke, C. E. Madu, O. A. Aiyegoro, T. A. Stenström, and A. I. Okoh, Antibiogram and beta-lactamase genes among cefotaxime resistant E. coli from wastewater treatment plant, Antimicrobial Resistance and Infection Control, vol. 9, no. 1, Mar. 2020, Art. no. 46. https://doi.org/10.1186/s13756-020-0702-4
[16] R. S. P. Sah, B. Dhungel, B. K. Yadav, N. Adhikari, U. T. Shrestha, B. Lekhak, M. R. Banjara, B. Adhikari, P. Ghimire, and K. R. Rijal, Detection of TEM and CTX-M genes in Escherichia coli isolated from clinical specimens at Tertiary Care Heart Hospital, Kathmandu, Nepal, Diseases, vol. 9, no. 1, Feb. 2021, Art. no. 15. https://doi.org/10.3390/diseases9010015
[17] I. L. Brito, Examining horizontal gene transfer in microbial communities, Nature Reviews Microbiology, vol. 19, pp. 442–453, Apr. 2021. https://doi.org/10.1038/s41579-021-00534-7
[18] J. Davies and D. Davies, Origins and evolution of antibiotic resistance, Microbiologia, vol. 12, no. 1, pp. 9–16, Mar. 1996. https://doi.org/10.1128/mmbr.00016-10
[19] H. Takada, Z. F. Mandell, H. Yakhnin, A. Glazyrina, S. Chiba, T. Kurata, K. J. Y. Wu, B. I. C. Tresco, A. G. Myers, G. C. Aktinson, P. Babizke, and V. Hauryliuk, Expression of Bacillus subtilis ABCF antibiotic resistance factor VmlR is regulated by RNA polymerase pausing, transcription attenuation, translation attenuation and (p)ppGpp, Nucleic Acids Research, vol. 50, iss. 11, pp. 6174–6189, Jun. 2022. https://doi.org/10.1093/nar/gkac497
[20] M. Bonnet, J. C. Lagier, D. Raoult, and S. Khelaifia, Bacterial culture through selective and non-selective conditions: the evolution of culture media in clinical microbiology, New Microbes and New Infections, vol. 34, Mar. 2020, Art. no. 100622. https://doi.org/10.1016/j.nmni.2019.100